Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trials

In two pivotal efficacy studies (ZOE-50; ZOE-70), the adjuvanted recombinant zoster vaccine (RZV) demonstrated >90% efficacy against herpes zoster (HZ). Adults aged ≥50 or ≥70 years (ZOE-50 [NCT01165177]; ZOE-70 [NCT01165229]) were randomized to receive 2 doses of RZV or placebo 2 months apart. V...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Lidia Oostvogels (Author), Thomas C. Heineman (Author), Robert W. Johnson (Author), Myron J. Levin (Author), Janet E. McElhaney (Author), Peter Van den Steen (Author), Toufik Zahaf (Author), Alemnew F. Dagnew (Author), Roman Chlibek (Author), Javier Diez-Domingo (Author), Iris S. Gorfinkel (Author), Caroline Hervé (Author), Shinn-Jang Hwang (Author), Hideyuki Ikematsu (Author), George Kalema (Author), Himal Lal (Author), Shelly A. McNeil (Author), Tomas Mrkvan (Author), Karlis Pauksens (Author), Jan Smetana (Author), Daisuke Watanabe (Author), Lily Yin Weckx (Author), Anthony L. Cunningham (Author)
Format: Knjiga
Izdano: Taylor & Francis Group, 2019-12-01T00:00:00Z.
Teme:
Online dostop:Connect to this object online.
Oznake: Označite
Brez oznak, prvi označite!

Internet

Connect to this object online.

3rd Floor Main Library

Podrobnosti zaloge 3rd Floor Main Library
Signatura: A1234.567
Kopija 1 Prosto